A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adults With Schizophrenia or Bipolar Disorder Treated With Antipsychotic Medications
Public ClinicalTrials.gov record NCT03818256. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adult Patients With Schizophrenia or Bipolar Disorder and Recent Weight Gain While Taking Antipsychotic Medications (GRATITUDE)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This phase 2, double blind, placebo-controlled, randomized study is to assess the safety, efficacy, and pharmacokinetics (PK) of miricorilant (CORT118335) in obese adults with schizophrenia or bipolar disorder treated with antipsychotic medications.
Study identification
- NCT ID
- NCT03818256
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 71 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 4, 2019 (Actual)
- Primary completion
- Jun 17, 2022 (Actual)
- Completion
- Jul 6, 2022 (Actual)
- Last update posted
- Sep 19, 2024
2019 – 2022
United States locations
- U.S. sites
- 27
- U.S. states
- 14
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 143 | Bentonville | Arkansas | 72712 | — |
| Site 249 | Little Rock | Arkansas | 72211 | — |
| Site 153 | Culver City | California | 90230 | — |
| Site 239 | Garden Grove | California | 92845 | — |
| Site 134 | Lemon Grove | California | 91945 | — |
| Site 126 | Oakland | California | 94607 | — |
| Site 163 | Oceanside | California | 92056 | — |
| Site 229 | Rancho Cucamonga | California | 91730 | — |
| Site 202 | Miami | Florida | 33122 | — |
| Site 144 | North Miami | Florida | 33161 | — |
| Site 241 | Okeechobee | Florida | 34972 | — |
| Site 140 | Chicago | Illinois | 60641 | — |
| Site 140 | Lincolnwood | Illinois | 60712 | — |
| Site 146 | Wichita | Kansas | 67214 | — |
| Site 138 | Glen Burnie | Maryland | 20161 | — |
| Site 151 | Las Vegas | Nevada | 89102 | — |
| Site 216 | New York | New York | 10032 | — |
| Site 181 | Raleigh | North Carolina | 27608 | — |
| Site 181 | Raleigh | North Carolina | 27610 | — |
| Site 107 | Dayton | Ohio | 45417 | — |
| Site 235 | Thorndale | Pennsylvania | 19372 | — |
| Site 235 | West Chester | Pennsylvania | 19380 | — |
| Site 206 | DeSoto | Texas | 75115 | — |
| Site 066 | Houston | Texas | 77030 | — |
| Site 165 | Richardson | Texas | 75080 | — |
| Site 139 | Salt Lake City | Utah | 84105 | — |
| Site 137 | Bellevue | Washington | 98007 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03818256, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 19, 2024 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03818256 live on ClinicalTrials.gov.